<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Akums Drugs and Pharmaceuticals Limited

NSE: AKUMS

Akums Drugs and Pharmaceuticals Limited Share Price & Analysis

552.55 -1.18%Updated 5 May 2026, 11:31 am IST
LTP
552.55
-1.18%
Open
High
562.1
Low
550
Close
₹552.55
52W High
52W Low
Volume
48K
Lot Size
1
Sector
Market Cap
Face Value

Price Chart

About Akums Drugs and Pharmaceuticals Limited

Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services.[1]

Frequently Asked Questions

What is Akums Drugs and Pharmaceuticals Limited share price today?
Akums Drugs and Pharmaceuticals Limited (AKUMS) is currently trading at ₹552.55 on NSE, down 1.18% as of the last market session. Prices update daily after market close on MarketNetra.
Is Akums Drugs and Pharmaceuticals Limited available in F&O (Futures & Options)?
Yes, Akums Drugs and Pharmaceuticals Limited (AKUMS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Akums Drugs and Pharmaceuticals Limited 52-week high and low?
Akums Drugs and Pharmaceuticals Limited's 52-week price range is tracked daily on MarketNetra. Check the overview page for the latest 52W high/low figures sourced from NSE.
What is Akums Drugs and Pharmaceuticals Limited P/E ratio?
Akums Drugs and Pharmaceuticals Limited's P/E ratio and other fundamental metrics including P/B, ROE, and ROCE are available on the overview page. Data is sourced weekly from Screener.in.
How to trade Akums Drugs and Pharmaceuticals Limited options?
Akums Drugs and Pharmaceuticals Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade AKUMS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.